HBIO vs PG · rev $86.5M vs P/E 25, rev $84.28B
Harvard Bioscience Inc (HBIO) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported HBIO revenue for 2025-12-31 was $86.5M. Net income was -$56.7M. Revenue was down 8.1% from 2024-12-31 to 2025-12-31. HBIO currently screens at market cap $20.3M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
HBIO currently screens at market cap $20.3M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the HBIO and PG stock pages for the full models.
Not investment advice.